Introduction: The role of intravenous tenecteplase (TNK) in patients with acute ischemic stroke presenting 4.5–24 hours after last known well remains uncertain. Methods: We performed a systematic review and frequentist and Bayesian meta-analysis of Randomized Controlled Trials (RCTs) comparing TNK-containing with trial-specific non-TNK strategies in imaging-selected patients with anterior-circulation large- or medium-vessel occlusion treated 4.5–24 hours after last known well. Trials represented heterogeneous reperfusion paradigms. The primary efficacy outcome was mRS 0-1 at 90 days; other functional, neurological, reperfusion, and recanalization outcomes were secondary or exploratory, and hemorrhagic events were assessed separately as safety outcomes. Results: Four multicenter RCTs comprising 1,589 patients were included. Frequentist analysis showed no significant difference in the primary outcome, mRS 0-1 at 90 days (OR 1.29, 95% CI 0.99–1.67), or in secondary functional outcomes and mortality. Symptomatic intracranial hemorrhage (OR 1.79, 95% CI 0.88–3.60) and parenchymal hematoma (OR 2.02, 95% CI 0.60–6.74) were numerically more frequent with TNK. No significant interaction was observed according to reperfusion strategy (P-interaction >0.36), although subgroup analyses were exploratory and underpowered. Bayesian analyses yielded estimates favoring TNK for excellent functional outcome (OR 1.29, 95% CrI 1.10–1.51) but also suggested increased risks of symptomatic intracranial hemorrhage (OR 1.79, 95% CrI 1.15–2.76) and parenchymal hematoma (OR 2.02, 95% CrI 1.14–3.47); these findings should be interpreted cautiously given their dependence on Bayesian model assumptions. Conclusion: Across heterogeneous reperfusion paradigms, TNK-containing strategies showed no consistent functional benefit, while hemorrhagic outcomes raised a potential safety signal. Pooled estimates should not be interpreted as a uniform treatment effect.
Introduction: Cardiac surgery anesthesia is associated with risks such as postoperative delirium (POD) and stress‐related responses. Benzodiazepines have been used perioperatively to reduce anxiety and promote hemodynamic control. However, their use may increase the risk of delirium, particularly in older adults. This systematic review and meta‐analysis aims to evaluate the impact of perioperative benzodiazepine use on the incidence of POD in patients undergoing cardiac surgery. Methods: We systematically searched for randomized controlled trials (RCTs) and observational studies comparing benzodiazepines with placebo or nonbenzodiazepine drugs in adults undergoing cardiac surgery. The primary outcome was POD incidence; secondary outcomes included mini‐mental state examination (MMSE), ICU length of stay, and time to extubation. For dichotomous outcomes, odds ratios (ORs) with 95% confidence intervals (CIs) were calculated, while mean differences (MDs) were used for continuous outcomes. Analyses were performed using R 4.4.3. Results: Eight studies were included, comprising 36,301 patients, of whom 20,747 (68.5%) received benzodiazepines. Follow‐up ranged from 1 day to 12 months. There were no significant differences between groups in the incidence of POD (OR 1.05; 95% CI: 0.88 to 1.25; p = 0.55; I 2 = 83%). Similarly, there were no significant difference in MMSE score (MD ‐0.11; 95% CI: −3.17 to 2.95; p = 0.94; I 2 = 70%), ICU length of stay (MD 4.72 h; 95% CI: −1.37 to 10.80; p = 0.13; I 2 = 99%), and time to extubation (MD ‐0.53 h; 95% CI: −2.16 to 1.09; p = 0.52; I 2 = 72%). Conclusion: Perioperative benzodiazepine use was not significantly associated with POD or with secondary outcomes in adults undergoing cardiac surgery.